Comparison of the preoperative and postoperative BSCVAs showed a statistically significant change in vision (p = 0.0356). Before surgery, the mean Snellen BSCVA was 20/90, whereas after surgery, BSCVA increased to 20/60. Sixty-five percent of the patients had an improved BSCVA, with an average gain of 3.7 lines per patient (range, +2 to +10). Fifteen percent of the patients lost an average of 3.0 lines (range, -2 to -6), and 20% had no change. UVA averaged 20/180 before surgery and 20/123 after surgery, but the change was not statistically significant. With respect to UVA, 63% improved by an average of 4.25 lines per patient (range, +2 to +9). Twenty-six percent (26%) lost an average of 5.6 lines (range, -2 to -8), and 10% had no change. The average follow-up time was 8 months for both BSCVA and UVA. When patients were stratified by their treatment indications and ranked in order of BSCVA outcome, patients with Salzmann's nodular degeneration did the best, followed by those with prior refractive surgery, corneal dystrophies, and corneal scars. Even though BSCVA did not improve as much in the corneal scar group, 50% of the patients reported an improvement in the symptoms they experienced before surgery based on questionnaires. Conclusion. BioMask appears to have potential as an ablatable mask material when used in conjunction with PTK for the treatment of corneal surface irregularities.
We have been using a 193-nm excimer laser under protocol to ablate the corneal stromal bed after creating a hinged corneal flap with a microkeratome in order to reduce or eliminate refractive error. Thirty-one consecutive eyes are reviewed with a preoperative mean spherical equivalent refraction of -6.25 diopters (D) (range -3.50 to -11.75 D). Preoperative mean astigmatism was +0.87 D (range +0.25 to +2.75 D). At 6 months postoperatively, the mean spherical equivalent refraction was -0.50 D (range -3.50 to +2.00 D). Mean postoperative astigmatism was 0.64 D (range 0.25 to 3.50 D). A result within 1.00 D of attempted correction was achieved in 74.2% of eyes. Uncorrected visual acuity after a single procedure was 20/40 or better in 81% of eyes. Spectacle corrected visual acuity was unchanged in 26 (84%), decreased 1/2 line in 2 (6%), and increased 2 lines in 1 (3%). The incidence of postoperative complications was minimal. Excimer laser ablation in the stromal bed in combination with a hinged corneal flap seems to offer many advantages over excimer laser surface ablation with fewer complications. [J Refract Surg. 1995;11(suppl.):S244-S247.]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.